NEW YORK, Aug. 12 -- Casa Bonita Music is releasing their
much anticipated debut album, Casa Bonita Music Compilation 2008, featuring
the hot hits from red-hot Caribbean artist like Como Ol' Vidarte from Mass
Histeria, Dime Que Paso from Desconocidos and Shake Your Body Like An M-1
from Top Legrand. Just made available on iTunes, it will impinge on the stores on
September 12, 2008.
The production house of Casa Bonita Music specializes in Reggaeton,
Reggae, Romantica and Bachata music with a fresh approach to their
musicalness, adding the much longed for infusion of somebody, rock and sweet
melodics that ring true with today's Latin listeners. Muy Caliente!
Casa Bonita Music began in 2006 with President Tommy Mouscardy and
Producer Ky Miller with its headquarters in New York and the Dominican
Republic where the recording and production took station for the entire
album. It is also in the Dominican Republic and Haiti that 5% of all the
record gross revenue will go toward charities for the children and residents.
All the creative person on Casa Bonita Music Compilation 2008, Mass Histeria,
Desconocidos and Top Legrand will begin touring in the United States this
fall of 2008.
Casa Bonita Music is releasing their debut record album of Casa Bonita Music
Compilation 2008 in stores September 12, 2008. With distribution by
Antillas Records in New York City and iTunes, the album is jammed with
fresh beats and already the Bachata 'Mira Mi' is turning heads. Touring
begins this fall in New York City. Go to hTTP://www.casabonitamusic.com for
touring dates and locations. iTunes:
http://phobos.apple.com/WebObjects/MZStore.woa/wa/viewAlbum?playList
Id=281396544 (Due to the length of the URL, copy and paste into browser).
More information
Wednesday 20 August 2008
Sunday 10 August 2008
PSA Dynamics And Nomograms In The Diagnosis And Treatment Planning For Prostate Cancer
�UroToday.com - The innovation of PSA as a marker for prostate crab has dramatically altered how prostate genus Cancer is diagnosed and treated. Along with the improvements in diagnosing and discourse options has come the realization that as workforce age prostate gland cancer is relatively usual and that not all prostate crab is fatal and needfully needs to be actively treated.
Almost as presently as PSA was introduced into widespread use, efforts were underway to increment diagnostic sensitivity and specificity, to place those populations of men who would benefit from screening and to tell intermediate and high risk of infection disease from the small risk diverseness. PSA can be elevated for a number of reasons and distinguishing benign from malignant elevations remains one of the most important areas of on-going research.
This presentation testament review the current options in consumption for improving the diagnostic accuracy of PSA and will include PSA-density, free and bound PSA, PSA-velocity and PSA doubling time. A give-and-take of which of these PSA based-options is nigh appropriate for specific situations will also undertaken.
In the brand diagnostic site the persona of PSA and its variants as a portent tool will also be reviewed as will diagnostic and prognostication nomograms.
Recent abstracts from the American Society of Clinical Oncology and the American Urological Association meetings will be reviewed and the attendant should experience a clear understanding of the use of these various modalities following this presentation.
Finally, the current options for prostatic biopsy and the benefits and problems with the expanded regimens ar discussed.
Presented by: Thomas Keane, MD, at the Masters in Urology Meeting - July 31, 2008 - August 2, 2008, Elbow Beach Resort, Bermuda
UroToday - the only urogenital medicine website with original mental object written by global urology key public opinion leaders actively engaged in clinical practice.
To access the latest urogenital medicine news releases from UroToday, go to:
www.urotoday.com
Copyright � 2008 - UroToday
More info
Almost as presently as PSA was introduced into widespread use, efforts were underway to increment diagnostic sensitivity and specificity, to place those populations of men who would benefit from screening and to tell intermediate and high risk of infection disease from the small risk diverseness. PSA can be elevated for a number of reasons and distinguishing benign from malignant elevations remains one of the most important areas of on-going research.
This presentation testament review the current options in consumption for improving the diagnostic accuracy of PSA and will include PSA-density, free and bound PSA, PSA-velocity and PSA doubling time. A give-and-take of which of these PSA based-options is nigh appropriate for specific situations will also undertaken.
In the brand diagnostic site the persona of PSA and its variants as a portent tool will also be reviewed as will diagnostic and prognostication nomograms.
Recent abstracts from the American Society of Clinical Oncology and the American Urological Association meetings will be reviewed and the attendant should experience a clear understanding of the use of these various modalities following this presentation.
Finally, the current options for prostatic biopsy and the benefits and problems with the expanded regimens ar discussed.
Presented by: Thomas Keane, MD, at the Masters in Urology Meeting - July 31, 2008 - August 2, 2008, Elbow Beach Resort, Bermuda
UroToday - the only urogenital medicine website with original mental object written by global urology key public opinion leaders actively engaged in clinical practice.
To access the latest urogenital medicine news releases from UroToday, go to:
www.urotoday.com
Copyright � 2008 - UroToday
More info
Subscribe to:
Posts (Atom)